HuGE Literature Finder
Records 1-13
Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.
Gene 2020 Jan 734 144391. Elshazli Rami M, Toraih Eman A, Elgaml Abdelaziz, Kandil Emad, Fawzy Manal |
Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis.
Cancer management and research 2018 10 1341-1349. Dong Zhiyong, Zheng Longzhi, Liu Weimin, Wang Cunchu |
Increased Frequency of KRAS Mutations in African Americans Compared with Caucasians in Sporadic Colorectal Cancer.
Clinical and translational gastroenterology 2017 Oct 8 (10): e124. Staudacher Jonas J, Yazici Cemal, Bul Vadim, Zeidan Joseph, Khalid Ahmer, Xia Yinglin, Krett Nancy, Jung Barba |
KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
Oncotarget 2017 Jan . Du Lijun, Kim John J, Shen Jinhua, Chen Binrui, Dai Ni |
The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
Oncotarget 2016 Nov . Tian Xin, Dai Shundong, Sun Jing, Jiang Shenyi, Jiang Youho |
Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.
World journal of gastroenterology 2016 Aug 22 (30): 6944-54. Lo Nigro Cristiana, Ricci Vincenzo, Vivenza Daniela, Granetto Cristina, Fabozzi Teresa, Miraglio Emanuela, Merlano Marco |
Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas.
International journal of epidemiology 2015 Oct . Montazeri Zahra, Theodoratou Evropi, Nyiraneza Christine, Timofeeva Maria, Chen Wanjing, Svinti Victoria, Sivakumaran Shanya, Gresham Gillian, Cubitt Laura, Carvajal-Carmona Luis, Bertagnolli Monica M, Zauber Ann G, Tomlinson Ian, Farrington Susan M, Dunlop Malcolm G, Campbell Harry, Little Juli |
Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis.
Genetics research 2015 97 e7. Khan Mohammad Haroon, Khalil Aftab, Rashid Ham |
Association between the p73 exon 2 G4C14-to-A4T14 polymorphism and cancer risk: a meta-analysis.
DNA and cell biology 2012 Feb 31 (2): 230-7. Hu Yi, Jiang Lan, Zheng Jian, You Yonghe, Zhou Yifeng, Jiao Shuncha |
TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.
Molecular biology reports 2011 Nov 38 (8): 4847-53. Wang Jing-Jun, Zheng Yuan, Sun Liang, Wang Li, Yu Peng-Bo, Dong Jian-Hua, Zhang Lei, Xu Jing, Shi Wei, Ren Yu-Ch |
TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jul 19 (7): 1840-7. Dahabreh Issa J, Linardou Helena, Bouzika Peggy, Varvarigou Vasileia, Murray Samu |
Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis.
Carcinogenesis 2010 Apr 31 (4): 643-7. Hu Zheng, Li Xiang, Qu Xincai, He Yungang, Ring Brian Z, Song Enmin, Su |
Polymorphisms and colorectal tumor risk.
Gastroenterology 2001 Aug 121 (2): 282-301. Houlston RS, Tomlinson IP |
- Page last reviewed:Oct 1, 2020
- Page last updated:Feb 24, 2021
- Content source: